Natural Product ID:   | NPC315334 |
Common Name:   | Lividomycin |
IUPAC Name:   | (2R,3S,4S,5S,6R)-2-[(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,5S,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-4-hydroxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
Synonyms:   | Lividomycin |
Molecular Formula:   | C29H55N5O18 |
Standard InCHIKey:   | DBLVDAUGBTYDFR-SWMBIRFSSA-N |
Standard InCHI:   | InChI=1S/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+/m1/s1 |
Canonical SMILES:   | OC[C@H]1O[C@H]([C@@H]([C@@H]1O[C@H]1O[C@@H](CN)[C@H]([C@@H]([C@H]1N)O)O[C@H]1O[C@H](CO)[C@H]([C@@H]([C@@H]1O)O)O)O)O[C@@H]1[C@@H](O)[C@H](N)C[C@@H]([C@H]1O[C@H]1O[C@H](CO)[C@H](C[C@H]1N)O)N |
First Find Year:   | |
Max Developmental Stage:   | |
Synthetic Gene Cluster:   | BGC0000708 ; |
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO18220.1 | Streptomyces lividus 2230-n1 | Subspecies | Streptomycetaceae | Bacteria | StreptomeDB* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT317 | Uncleic Acid | Nucleic Acid | MIC | = | 10000 | nM | 9457241 | |
NPT144 | Individual Protein | Telomerase reverse transcriptase | Homo sapiens | Inhibition | = | 50 | % | 15177454 |
NPT144 | Individual Protein | Telomerase reverse transcriptase | Homo sapiens | Inhibition | = | 12 | % | 15177454 |
NPT2 | Others | Unspecified | Inhibition | = | 0 | % | 15177454 | |
NPT2 | Others | Unspecified | Inhibition | = | 10 | % | 15177454 | |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 4 | ug/ml | 17088477 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 8 | ug/ml | 17088477 |
NPT1521 | Organism | Stenotrophomonas maltophilia | Stenotrophomonas maltophilia | MIC | = | 128 | ug/ml | 17088477 |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 28 | nM | 19445516 | |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 256 | ug/ml | 17875999 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 16 | ug/ml | 17875999 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 0.5 | ug/ml | 17875999 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 32 | ug/ml | 17875999 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 2 | ug/ml | 17875999 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC315334 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9651 | High Similarity | NPC176381 |
0.9651 | High Similarity | NPC195969 |
0.9419 | High Similarity | NPC314007 |
0.9419 | High Similarity | NPC43850 |
0.9419 | High Similarity | NPC214376 |
0.9419 | High Similarity | NPC314408 |
0.9419 | High Similarity | NPC123746 |
0.9419 | High Similarity | NPC477060 |
0.9302 | High Similarity | NPC313552 |
0.8837 | High Similarity | NPC263058 |
0.8737 | High Similarity | NPC315036 |
0.8721 | High Similarity | NPC315969 |
0.871 | High Similarity | NPC330590 |
0.8488 | Intermediate Similarity | NPC318258 |
0.8163 | Intermediate Similarity | NPC56298 |
0.8163 | Intermediate Similarity | NPC471628 |
0.7642 | Intermediate Similarity | NPC121479 |
0.7642 | Intermediate Similarity | NPC57436 |
0.7474 | Intermediate Similarity | NPC306838 |
0.7404 | Intermediate Similarity | NPC221148 |
0.7216 | Intermediate Similarity | NPC470282 |
0.7174 | Intermediate Similarity | NPC316807 |
0.7117 | Intermediate Similarity | NPC241597 |
0.7097 | Intermediate Similarity | NPC83248 |
0.7097 | Intermediate Similarity | NPC100204 |
0.7097 | Intermediate Similarity | NPC70574 |
0.7093 | Intermediate Similarity | NPC129100 |
0.7093 | Intermediate Similarity | NPC291650 |
0.7093 | Intermediate Similarity | NPC322801 |
0.7053 | Intermediate Similarity | NPC165119 |
0.6989 | Remote Similarity | NPC98750 |
0.6947 | Remote Similarity | NPC271772 |
0.6947 | Remote Similarity | NPC36927 |
0.6923 | Remote Similarity | NPC94319 |
0.6765 | Remote Similarity | NPC328646 |
0.6667 | Remote Similarity | NPC471420 |
0.6577 | Remote Similarity | NPC317534 |
0.6566 | Remote Similarity | NPC192025 |
0.6566 | Remote Similarity | NPC253975 |
0.6566 | Remote Similarity | NPC125253 |
0.65 | Remote Similarity | NPC83839 |
0.6471 | Remote Similarity | NPC470284 |
0.6458 | Remote Similarity | NPC150557 |
0.6321 | Remote Similarity | NPC470283 |
0.6304 | Remote Similarity | NPC223174 |
0.6304 | Remote Similarity | NPC327753 |
0.6304 | Remote Similarity | NPC327486 |
0.6279 | Remote Similarity | NPC290179 |
0.6279 | Remote Similarity | NPC317023 |
0.6279 | Remote Similarity | NPC34877 |
0.6273 | Remote Similarity | NPC42320 |
0.6273 | Remote Similarity | NPC188453 |
0.6154 | Remote Similarity | NPC314306 |
0.6134 | Remote Similarity | NPC313813 |
0.6132 | Remote Similarity | NPC208537 |
0.6132 | Remote Similarity | NPC270005 |
0.6111 | Remote Similarity | NPC6848 |
0.6098 | Remote Similarity | NPC20035 |
0.602 | Remote Similarity | NPC314772 |
0.602 | Remote Similarity | NPC314968 |
0.6 | Remote Similarity | NPC59589 |
0.6 | Remote Similarity | NPC68327 |
0.5922 | Remote Similarity | NPC476523 |
0.5889 | Remote Similarity | NPC17455 |
0.5877 | Remote Similarity | NPC239705 |
0.5877 | Remote Similarity | NPC314398 |
0.5877 | Remote Similarity | NPC314413 |
0.584 | Remote Similarity | NPC139857 |
0.5833 | Remote Similarity | NPC474468 |
0.5826 | Remote Similarity | NPC322449 |
0.5826 | Remote Similarity | NPC189854 |
0.5826 | Remote Similarity | NPC92874 |
0.5826 | Remote Similarity | NPC62845 |
0.5826 | Remote Similarity | NPC166242 |
0.5816 | Remote Similarity | NPC244539 |
0.5802 | Remote Similarity | NPC262050 |
0.5795 | Remote Similarity | NPC472025 |
0.5776 | Remote Similarity | NPC10897 |
0.5776 | Remote Similarity | NPC325900 |
0.5758 | Remote Similarity | NPC313762 |
0.5748 | Remote Similarity | NPC75839 |
0.5729 | Remote Similarity | NPC52268 |
0.5729 | Remote Similarity | NPC53760 |
0.5698 | Remote Similarity | NPC323361 |
0.5698 | Remote Similarity | NPC145112 |
0.5698 | Remote Similarity | NPC67660 |
0.5698 | Remote Similarity | NPC89145 |
0.5698 | Remote Similarity | NPC242073 |
0.5698 | Remote Similarity | NPC58629 |
0.5698 | Remote Similarity | NPC157514 |
0.5698 | Remote Similarity | NPC269166 |
0.5698 | Remote Similarity | NPC130683 |
0.5698 | Remote Similarity | NPC107914 |
0.5698 | Remote Similarity | NPC165198 |
0.5698 | Remote Similarity | NPC246558 |
0.5684 | Remote Similarity | NPC250619 |
0.5684 | Remote Similarity | NPC67099 |
0.5632 | Remote Similarity | NPC303727 |
0.5604 | Remote Similarity | NPC477755 |
0.5604 | Remote Similarity | NPC477762 |
0.5604 | Remote Similarity | NPC477753 |
0.5604 | Remote Similarity | NPC477763 |
0.5604 | Remote Similarity | NPC472026 |
0.5604 | Remote Similarity | NPC477750 |
0.5604 | Remote Similarity | NPC477757 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC315334 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9651 | High Similarity | NPD5794 | Approved |
0.9651 | High Similarity | NPD5795 | Approved |
0.9651 | High Similarity | NPD5797 | Approved |
0.9651 | High Similarity | NPD5798 | Approved |
0.9651 | High Similarity | NPD5796 | Clinical (unspecified phase) |
0.9419 | High Similarity | NPD3201 | Approved |
0.9419 | High Similarity | NPD3203 | Approved |
0.9419 | High Similarity | NPD2698 | Approved |
0.9419 | High Similarity | NPD3208 | Approved |
0.9419 | High Similarity | NPD3209 | Approved |
0.9419 | High Similarity | NPD3202 | Approved |
0.9419 | High Similarity | NPD3207 | Approved |
0.9302 | High Similarity | NPD3200 | Clinical (unspecified phase) |
0.871 | High Similarity | NPD5377 | Approved |
0.871 | High Similarity | NPD5378 | Approved |
0.871 | High Similarity | NPD5381 | Approved |
0.8333 | Intermediate Similarity | NPD4282 | Approved |
0.8163 | Intermediate Similarity | NPD4837 | Approved |
0.8163 | Intermediate Similarity | NPD4836 | Approved |
0.8163 | Intermediate Similarity | NPD4835 | Approved |
0.8163 | Intermediate Similarity | NPD4838 | Approved |
0.7941 | Intermediate Similarity | NPD5376 | Approved |
0.7642 | Intermediate Similarity | NPD35 | Approved |
0.7642 | Intermediate Similarity | NPD4833 | Approved |
0.7404 | Intermediate Similarity | NPD1449 | Approved |
0.7404 | Intermediate Similarity | NPD1450 | Approved |
0.7117 | Intermediate Similarity | NPD3731 | Phase 3 |
0.7093 | Intermediate Similarity | NPD9030 | Approved |
0.7093 | Intermediate Similarity | NPD9031 | Approved |
0.7093 | Intermediate Similarity | NPD9032 | Approved |
0.7093 | Intermediate Similarity | NPD9033 | Approved |
0.7091 | Intermediate Similarity | NPD2690 | Discontinued |
0.7009 | Intermediate Similarity | NPD2700 | Approved |
0.6991 | Remote Similarity | NPD4832 | Approved |
0.6991 | Remote Similarity | NPD4831 | Approved |
0.6991 | Remote Similarity | NPD4830 | Approved |
0.699 | Remote Similarity | NPD6428 | Approved |
0.6923 | Remote Similarity | NPD4828 | Approved |
0.6923 | Remote Similarity | NPD4827 | Approved |
0.6923 | Remote Similarity | NPD4826 | Approved |
0.6813 | Remote Similarity | NPD9034 | Approved |
0.6813 | Remote Similarity | NPD67 | Phase 2 |
0.678 | Remote Similarity | NPD6436 | Phase 3 |
0.6759 | Remote Similarity | NPD8045 | Clinical (unspecified phase) |
0.6514 | Remote Similarity | NPD7141 | Clinical (unspecified phase) |
0.6514 | Remote Similarity | NPD7139 | Approved |
0.6514 | Remote Similarity | NPD7140 | Approved |
0.6466 | Remote Similarity | NPD3204 | Clinical (unspecified phase) |
0.646 | Remote Similarity | NPD6941 | Approved |
0.6449 | Remote Similarity | NPD881 | Approved |
0.6408 | Remote Similarity | NPD3716 | Discontinued |
0.6322 | Remote Similarity | NPD6123 | Approved |
0.6304 | Remote Similarity | NPD9445 | Approved |
0.6154 | Remote Similarity | NPD6430 | Approved |
0.6154 | Remote Similarity | NPD6429 | Approved |
0.602 | Remote Similarity | NPD9435 | Approved |
0.602 | Remote Similarity | NPD9434 | Approved |
0.5983 | Remote Similarity | NPD8087 | Discontinued |
0.5935 | Remote Similarity | NPD8347 | Approved |
0.5935 | Remote Similarity | NPD8346 | Approved |
0.5935 | Remote Similarity | NPD8345 | Approved |
0.5926 | Remote Similarity | NPD1446 | Phase 3 |
0.5926 | Remote Similarity | NPD1447 | Phase 3 |
0.5905 | Remote Similarity | NPD4759 | Clinical (unspecified phase) |
0.5873 | Remote Similarity | NPD591 | Approved |
0.5873 | Remote Similarity | NPD577 | Phase 3 |
0.5812 | Remote Similarity | NPD8174 | Phase 2 |
0.5804 | Remote Similarity | NPD2255 | Approved |
0.5698 | Remote Similarity | NPD894 | Approved |
0.5698 | Remote Similarity | NPD887 | Approved |
0.5698 | Remote Similarity | NPD888 | Phase 3 |
0.5698 | Remote Similarity | NPD893 | Approved |
0.5698 | Remote Similarity | NPD895 | Approved |
0.5698 | Remote Similarity | NPD892 | Phase 3 |
0.5698 | Remote Similarity | NPD889 | Approved |
0.5698 | Remote Similarity | NPD890 | Clinical (unspecified phase) |
0.5698 | Remote Similarity | NPD891 | Phase 3 |
0.5632 | Remote Similarity | NPD7346 | Approved |
0.56 | Remote Similarity | NPD372 | Clinical (unspecified phase) |
PubChem CID   | 72394 |
ChEMBL   | CHEMBL389029 |
ZINC   |
Molecular Weight:   | 761.35 |
ALogP:   | -10.5437 |
MLogP:   | 2.12 |
XLogP:   | -8.641 |
# Rotatable Bonds:   | 27 |
Polar Surface Area:   | 406.24 |
# H-Bond Aceptor:   | 23 |
# H-Bond Donor:   | 15 |
# Rings:   | 5 |
# Heavy Atoms:   | 52 |